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1. Introduction 
4Aminobutyric acid (GABA) functions in mam- 
malian brain as an inhibitory neurotransmitter. The 
synthesis of GABA is catalysed by L-glutamate decar- 
boxylase (EC 4.1 .l .I 5, GAD) and it is degraded by 
the consecutive action of 4-aminobutyrate-2-oxo- 
glutarate aminotr~sferase (EC 2.6.1.19, GABA-T) 
and succinic semialdehyde dehydrogenase (EC 
1.2.1.16, SSA-DH). The activities of the GABA shunt 
enzymes listed above have been reported to be affect- 
ed by monovalent and bivalent cations in vitro 
[l--6]. 
The aliphatic amines putrescine, spermidine and 
spermine, commonly referred to as polyamines, are 
present in relatively high concentrations in mamma- 
lian nervous tissue. The polyamines influence nu- 
merous biochemical functions, in which they have 
been regarded as acting as cations (reviewed [7-lo]). 
In vivo studies [ 1 l-131 suggest hat there may be 
regulatory interrelations between polyamines and 
GABA in the mammalian nervous tissue. Here we 
investigate the effects of the 3 polyamines on the 
enzymes of the GABA shunt in vitro in order to ob- 
tain information on their possible roles in regulating 
the activities of these enzymes. 
We report a significant inhibition of SSA-DH by 
spermidine and to a lesser degree by spermine. The 
reversible inhibition by spermidine was hyperbolic 
and non-competitive in respect of both of the sub- 
strates, succinic semialdehyde (SSA) and NAD. The 
app. Ki of spermidine was <OS mM. Spermidine and 
spermine also caused an indirect inhibition of 
GABA-T . 
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2. Materials and methods 
SSA was synthetized from monosodium glutamate 
as in [2]. [U-14C]GABA (4.6 mCi/mmol) was obtain- 
ed from the Radiochemical Centre, Amersham and 
L~[U”‘4C]glutamic acid (260 mCi/mmol) from the 
NEN Corp., Boston, MA, All other chemicals were 
from the usual commercial sources and of the highest 
purity available. 
The brains of randomly selected adult male mice 
(30 + 2 g) of the NMRI strain were used as the en- 
zyme source. The enzyme activities were determined 
essentially as in [ 141 for GAD and in [15] for SSA- 
DH. The radiochemi~al method [ 161 as modified in 
[ 151 was used for the GABA-T assays. The rever- 
sibility of the SSA-DH inhibition by spermidine was 
tested by gel filtration using a ready-packed PD-10 
desalting column (Pharmacia Fine Chemicals, Upp- 
sala). 
Since >5% of the initial concentration of SSA and 
NAD was converted in the assays of SSA-DH, the 
apparent kinetic constants were calculated using the 
integrated form of the Hens-Michae~s-Menten equa- 
tion [ 171. The amount of product formed 0) during 
the time t is plotted against t-l. In S&r, where So 
is the amount of substrate at zero time and S, that 
after time t. The Ki values were calculated from a 
replot of the ratio of the app. Km and V,, vs the 
concentration of inhibitor. 
All constants were calculated from the plots using 
the method of least squares. Covariance analysis for 
the regression lines was used to test the significance 
of the differences in K, and V,,. The significances 
of the values in table 1 vs the control values were 
tested using the Student’s t-test. 
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3. Results 
GAD activity was measured in a i~ediurn contain- 
ing 20 mM pyridoxal 5’-phosphate, 1 mM dithio- 
treitol, 32.5 mM sodium L-glutamate, 0.1 &i 
L-[U-14C~glutamic acid, 75 mM sodium phosphate 
buffer (pH 6.8) and 0.5 ml enzyme preparation in 
1 ml total vol. Incubation was for 60 min at 37°C. 
The effects of putrescine, spermidine and spermine 
on GAD activity were tested by including these in 
the reaction mixture as HCl salts in 5 mM final 
COW. Four duplicate deterf~inations for the control 
experiments and each polyamine were performed. 
The control value for GAD activity was 41.7 ct 
3.9 prnol COZ . g tissue (wet wt)-’ .60 min -r , and 
the assays containing the polyamines showed no sig- 
nificant differences from this (at least P < 0.01, data 
not included). 
The effects of the polyamines on GABA-T and 
SSA-DH activity are shown in table 1. The results 
indicate that the activity of both of the enzymes is 
significantly decreased by spermidine and spermine. 
The GABA-T assay is normally carried out in the 
presence of NAD, which makes it possible for the 
endogenous SSA-DH in the homogenate to convert 
the intermediate product, SSA, to succinic acid. As 
the inhibition of SSA-DH may be reflected in the 
activity of GABA-T through accumulating SSA [ 181, 
we have also determined the GABA-T activity in tlze 
absence of NAD. As NAD is excluded, the measured 
product will be SSA, which causes increasing product 
inhibition during the assay and makes the interpreta- 
tion of the results difficult. 
There were no marked differences in results when 
the effects of polyamines on GABA-T were assayed 
without NAD (table I). Also the time curves of 
product fortnation in all the assays lacking NAD were 
essentially identical (data not shown). This suggests 
that the inhibition of GABA-T, when assayed in the 
presence of NAD, is caused by the accumulating SSA 
and not by direct action of spermidine and spermine 
on the enzyme. 
Both the inhibition of SSA-DH and the indirect 
iIlIlibition of GABA-T turned out to be reversible 
in respect of the 2 polyamines, when they were 
removed from the mediutn by gel filtration. 
The kinetics of the strongest of the SSA-DH inhib- 
itors present, spermidine, were studied by using 
varied SSA concentrations at constant excess of NAD 
and vice versa at different spermidine ~onceiltrat~ons. 
The resulting integrated I~eJlri-Micliaelis-Menten plots 
are shown in fig.1. The slopes (i.e., Km) of the lines 
for the inhibited reactions did not deviate signi~~~lt- 
ly from that of the zero line in either case (at least 
P < O.Ol), whereas the intersections with the ordinate 
(i.e., I’,,) were signi~~antly affected in both cases. 
This indicates that the inhibition of SSA-DH by 
spermidine is noncompetitive in respect of both of 
the substrates. It may also be seen frotn the plots 
that the inhibition of SSA-DH by spermidine obeys 
Table 1 
Effect of polyamines on the activity of mouse brain GABA-T and SSA-DH 
in vitro 
Effector 
-~-_- 
Control 
Putrescine 
Spermidine 
Spermine 
.~_~ ~_ 
100.0 * 9.8 (8) 100.0 + 6.4 (8) 100.0 f 6.8 (8) 
99.6 f 11 .l (4) 95.4 i 7.4 (4) 99.9 * 8.2 (4) 
94.7 i 8.3 (8) 5 1.7 i 9.ga (8) 47.4 + 9.3” (8) 
102.0 * 5.9 (4) 84.1 t 4.4a (4) 78.8 f 4.3a (4) 
Relative activities f SD of the no. determinations hown in parentheses. Signif- 
icance vs control: aat least P < 0.01. The absolute control values for GABA-T 
without and with NAD were 21.4 * 2.1 and 39.2 * 2.5 pm01 product. g 
tissue-’ .60 min-‘, respectively and for SSA-DH 46.8 + 3.2 pmol NADH . g 
tissue-’ . 60 min-’ . GABA-T activity was measured with 2.22 mg tissue (wet 
wt)/ml, the incubation time being 60 min at 22°C. The medium contained: 
50 mM Tris-HCl (pH 8.5); 3 mM GABA; 0.1 $Zi [U-“C]GABA; 2 mM 2-0x0- 
glutarate; 20 mM mercaptoethanol; 1mM succinic acid; 0.9 mM NAD. Poly- 
amine was 2 mM. The conditions for the SSA-DH assay were the same as for 
GABA-T, except that 0.4 mM-SSA was used instead of GABA and [ U-W]GABA, 
2itxogIutarate and succinic acid were omitted 
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Fig.1. Integrated Henri-Michaelis-Menten curves to determine the effect of spermidine on the kinetic constants of SSA-DH. Incu- 
bation was carried out with 0.44 mg tissue (wet v&)/ml in 50 mM Tris-HCl (pH 8.5) at 22°C for 60 mm in the presence of 8.2 mM 
2-mercaptoethanol. (A) Inhibition by spermidine with respect to SSA. NAD was 0.25 mM. Spermidine: (0). no addition; (o), 
0.5 mM; (m), 1 mM; (n), 2 mM. The points represent means of 3 separate determinations carried out in duplicate. A replot to 
determine the Ki of spermidine in respect of SSA is inserted. The point representing 2 mM spermidine concentration in the 
repfot is excluded from the regression calculation, as it is clearly beyond the linear range of the inhibition. (Bf inhibition by 
spermidine in respect of NAD. SSA was 0.15 mM. The symbols are identical to those in (A). A similar replot for Ki determination 
is inserted. 
hyperbolic saturation kinetics. The app. lui values for 
spermidine, as calculated from the replots inserted in 
tig.lA,B are 0.20 mM and 0.47 mM, respectively. 
The apparent kinetic constants for mouse brain 
SSA-DH as calculated from plot IA are : V,,, 
52.3 pmol NADH . g tissue-’ .60 min-* ; 
KS,, 7.4 PM and from plot 1 B: V,, 58.3 pmol 
NADH . g tissue-’ .60 mm’ ; KNAD 36.9 PM. 
4. Discussion 
As the positively charged amino groups are the 
only functional components in the structure of the 
polyamines, it is obvious that these are responsible 
for the observed inhibition of SSA-DH. Since putres- 
tine had no effect on the activity of SSA-DH, as seen 
from table 1, it seems that the specific arrangement 
of the amino groups in spermidine is necessary for the 
inhibitory action. The same arrangement of amino 
groups is included in the structure of spermine, but 
the additional propylamino group in its structure 
possibly causes the weakening of the inhibition as 
compared with spermidine. The fact that the inhibi- 
tion of SSA-DH by spermidine was reversible, but 
independent of the concentration of the substrates, 
suggests that the site of action of the polyamine is 
different from the catalytically active site of the 
enzyme. 
It has been postulated [ 181 that the metabolism 
of SSA could be regulated in vivo through the effects 
of monovalent and bivalent cations on the activity of 
SSA-DH. There is also evidence that changes in the 
activity of SSA-DH might be reflected in the cerebral 
concentration of GABA and thus affect the func- 
tioning of the nervous system [ 181. The polyamines 
have certain advantages as compared with inorganic 
cations as possible regulators of SSA-DH, since their 
concentration can be regulated through metabolism 
in vivo. Active transport of polyamines within the 
nervous system [ 19,201 and into brain slices [ 2 l] 
has also been demonstrated. 
We reported [ 121 that in vivo treatment of mice 
with a known GAD inhibitor, D,L-allylglycine, caused 
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a decrease in the brain GABA level and also affected 
the activities of enzymes of polyamine synthesis and 
the brain polyamine levels. Electrical stimulation, 
which has been reported to reduce GABA levels in 
cerebral cortex [22], also caused marked increase in 
the activities of the regulatory enzymes of polyamine 
synthesis [ 111. It has also quite recently been report- 
ed that the increase of cerebral GABA level is reflect- 
ed in the polyamine metabolism [ 131. 
Spermidine and spermine in mouse brain are 0.33 
and 0.30 mmoljkg wet wt, respectively, as deter- 
mined from whole brain homogenate [ 121. The sper- 
mine concentration is relatively stable between differ- 
ent areas of mammalian nervous system, while the 
amount of spermidine shows considerable regional 
variation [23-25],0.34-1.4 mmol/kg having been 
reported for spermidine in different areas of the ner- 
vous system of the rat [25]. The Ki of spermidine for 
SSA-DH determined here, 0.35 mM (av. from the 
2 plots), is seen to be within the range of physiologi- 
cal concentrations of this polyamine. 
These results suggest hat there is a specific 
arrangement of electrically negative sites in the SSA- 
DH molecule with which spermidine in particular 
is capable of interacting strongly, causing a significant 
reversible and noncompetitive inhibition of the en- 
zyme. This finding might be of use when studying the 
structural features of the enzyme and when searching 
for specific inhibitors of SSA-DH. In spite of the 
known features mentioned above which suggest hat 
spermidine in particular may be of physiological 
significance in regulating cerebral GABA metabolism, 
further research is required to establish its possible 
role in this connection. 
This work was supported by a grant from the Med- 
ical Research Foundation (Helsinki, Finland). 
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